ION-674

N/A

Report date: 2023/01/14 21:32:25
NME

Base Information

Drug NameION-674
Drug Alias NameION-674
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionHistone-lysine N-methyltransferase EZH2 inhibitorsRNA interference
TargetsHistone-lysine N-methyltransferase EZH2
Therapy Area/IndicationsLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSuzhou Ribo Life Science Co LtdIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesIonis Pharmaceuticals IncSuzhou Ribo Life Science Co Ltd
Inactive CompaniesN/A
Active IndicationsLymphoma, Non-Hodgkin
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A